Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose vs High Dose Cyclophosphamide in Proliferative Lupus Nephritis
NCT02645565Phase 4Completed
- Sponsor
- JIPMER
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide in lupus nephritis (LN), sponsored by JIPMER. Started Dec 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02645565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645565.